Contract Notice Detail

Summary Information Summary Information Base Total Price: 21,807,000.000000 Euro   Forbid offers above base price:   Request Reference: PH-111029223   Request Name: Aquisição do Medicamento FARICIMAB 120 MG/ML SOL INJ FR 0.24 ML INTRAVITREO - 2023   Phase: Tendering Phase State: ClosedForReplies Description: Aquisição do Medicamento FARICIMAB 120 MG/ML SOL INJ FR 0.24 ML INTRAVITREO - 2023   Procedure Type: VortalGOV - Direct Award (ECP)   Object of the Contract Object of the Contract Type of Contract: Supplies Acquisition   Main Object CPV Main Category: Estrada do Forte do Alto do Duque 1449-005 Lisboa PORTUGAL   CPV Main Vocabulary 33600000-6 - Pharmaceutical products   CPV Supplementary Vocabulary   Additional Classifications List   Scheduling Scheduling Request online publishing date: 12/7/2023 8:24 AM (UTC 0 hours)   Due datetime for receiving replies: 12/11/2023 9:00 AM (UTC 0 hours)   Financial Settings Financial Settings Define Advance Payments? No   Define Warranties? No   Contract Documents Contract Documents Document Name Description Doc Classification 111029223 Caderno de Encargos.pdf 111029223 Caderno de Encargos.pdf Download 111029223 Convite.pdf 111029223 Convite.pdf Download Anexo I roche.xlsx Anexo I roche.xlsx Download Anexo II.xlsx Anexo II.xlsx Download Object of contract This contract is subject to renewal? No   The procurement is related to a project and/or programme financed by European Union funds? No   Legal, economic, financial and technical information The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons? No   Questionnaire Questionnaire     1   Questionário   1.1         Main Section   1.1.1         Articulado * (Os valores indicados não incluem o IVA) Solicitou requisitos adicionais nesta lista de preços.           Preço Total Total without VAT0,000000 EUR             Cód. Artigo Referência Interna Descrição Qt Unidade Preço Unitário Preço Total           Reference1 DescriptionAquisição do Medicamento FARICIMAB 120 MG/ML SOL INJ FR 0.24 ML INTRAVITREO - 2023           Reference1 Internal Reference DescriptionFARICImab 120 MG/ML SOL INJ FR 0.24 ML INTRAVITREO Qty30,000000 UnitFR Price per Unit Total Evaluation Evaluation Evaluation General Settings Evaluation General Settings Evaluation guideline MostEconomicallyAdvantageousTender   Evaluation Method Manual   Evaluation Items Evaluation Items Name Lot Critérios De Avaliação   Critérios de Adjudicação     Peso (%)**   1   Preço 100   Define tie breaking rules? YesNo     Public Messages Public Messages Type Reference Subject Date No items found...